Physician

Bruce C Mathey, MD

According to 2025 Medicare claims, Bruce Mathey, MD (NPI: 1366497463) practices hematology/oncology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is PUBLIC HOSPITAL DIST NO 1 SKAGIT (NPI: 1629012463; TIN: 562392010) and primary practice location at 98274-4100. Mathey is affiliated with the Cascadia Care Network LLC (ACO ID: A3731) and PSW ACO (ACO ID: A5323), participating under the MSSP model.

Mathey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 1,457 HCPCS/CPT codes, and received $110,768 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,431 prescription claims across 395 beneficiaries totaling $6,265,068 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 268 claims. Open Payments data shows 3 records totaling $152. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $34,316 to $110,768. Similarly, Part D prescription costs have risen steadily, from $752,047 to $6,265,068. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $6,364 to $14,332.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	119	534	$34,316
2016	316	1,493	$91,628
2017	358	1,603	$104,520
2018	419	1,530	$100,198
2019	364	1,548	$95,935
2020	442	1,700	$103,722
2021	401	1,450	$107,736
2022	426	1,652	$126,969
2023	411	1,374	$100,998
2024	427	1,457	$110,768

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	1,690	$752,047
2016	158	1,259	$885,787
2017	163	1,436	$1,221,041
2018	200	1,612	$1,284,885
2019	195	1,864	$1,519,952
2020	228	2,004	$2,925,530
2021	240	2,347	$3,089,288
2022	279	2,650	$3,275,286
2023	307	2,527	$2,815,479
2024	395	3,431	$6,265,068

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	77	$4,425
2016	N/R	144	$8,205
2017	N/R	175	$7,159
2018	N/R	108	$5,105
2019	N/R	109	$10,573
2020	N/R	254	$20,906
2021	44	201	$10,596
2022	N/R	311	$16,904
2023	35	365	$24,989
2024	53	268	$16,490

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	100	100	$133
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	92	96	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	370	1,098	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	30	74	$62
99442	Telephone medical discussion with physician, 11-20 minutes	43	51	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	90	2,268	$1,014,201
Imbruvica	Ibrutinib	57	1,636	$834,222
Xtandi	Enzalutamide	54	1,620	$808,195
Pomalyst	Pomalidomide	27	756	$618,521
Kisqali	Ribociclib Succinate	19	588	$328,681

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	14	33	$7,136
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$2,481
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	14	52	$2,209
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	12	42	$2,034
J9190	Injection, fluorouracil, 500 mg	N	13	62	$1,430

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$152	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bruce C. Mathey, MD?

Tedicare shows public-source Medicare data for Bruce C. Mathey, MD (NPI 1366497463), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bruce C. Mathey, MD have ACO affiliation data?

Bruce C. Mathey, MD is shown with ACO affiliation data for Cascadia Care Network LLC (MSSP, ACO ID A3731) and PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Bruce C. Mathey, MD?

Bruce C. Mathey, MD is linked to PUBLIC HOSPITAL DIST NO 1 SKAGIT (billing NPI 1629012463) in the available physician profile data.

Does Bruce C. Mathey, MD have Open Payments data?

Bruce C. Mathey, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.